Valneva SE
LSE:0OB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Valneva SE
LSE:0OB3
|
FR |
|
S
|
Sanlam Ltd
JSE:SLM
|
ZA |
|
C
|
Coca-Cola Europacific Partners PLC
SWB:CK0
|
UK |
|
Q
|
Qualcomm Inc
XETRA:QCI
|
US |
|
Trade Desk Inc
XETRA:TT8
|
US |
|
S
|
Securitas AB
SWB:S7MB
|
SE |
|
Dabur India Ltd
NSE:DABUR
|
IN |
|
S
|
Snap Inc
LSE:0RNH
|
US |
|
T
|
Tegna Inc
SWB:GTT
|
US |
|
G
|
Galderma Group AG
OTC:GDERF
|
CH |
|
S
|
Sysco Corp
DUS:SYY
|
US |
|
B
|
BCE Inc
SWB:BCE1
|
CA |
|
China Mobile Ltd
HKEX:941
|
CN |
|
Y
|
Yamaha Corp
F:YHA
|
JP |
|
Q
|
Qiagen NV
F:QIA
|
NL |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
|
G
|
Getlink SE
OTC:GRPTF
|
FR |
|
Nomura Holdings Inc
SGX:INC
|
JP |
|
W
|
Waters Corp
SWB:WAZ
|
US |
|
Bros Eastern Ltd
SSE:601339
|
CN |
|
S
|
Southern Copper Corp
LSE:0L8B
|
US |
|
Bryn Inc
OTC:BRRN
|
US |
|
Molson Coors Canada Inc
TSX:TPX.B
|
CA |
|
T
|
Tyson Foods Inc
SWB:TF7A
|
US |
Bankruptcy Probability
Valneva SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Valneva SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Valneva SE
PAR:VLA
|
266.6m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
228B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
76.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Valneva SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Valneva SE has total debt of 186.6m EUR. This includes both short-term (0 EUR) and long-term (186.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.